Warning Letters and Test Results for Cannabidiol-Related Products

“FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain.” We need a benchmark quality source of CBD for uniform clinical evaluation by payers, clinicians, and patients.

https://www.fda.gov/newsevents/publichealthfocus/ucm484109.htm

Leave a Reply

Your email address will not be published. Required fields are marked *